Molecular epidemiology of neonatal Gilbert's syndrome in Malaysia
马来西亚新生儿吉尔伯特综合症的分子流行病学
基本信息
- 批准号:15406036
- 负责人:
- 金额:$ 7.36万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:2003
- 资助国家:日本
- 起止时间:2003 至 2004
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
1 (Purpose) To clarify whether the UGT1A1 mutations contribute to the high incidence of neonatal jaundice in Southeast Asian populations, we screened for the mutations in the Malay-Malaysian populations. A total of 105 Malay-Malaysian newborn infants were enrolled in this study : 55 with jaundice and 50 without jaundice (non-jaundice). We used denaturing high-performance liquid chromatography (DHPLC) to detect the mutations, and GeneScan analysis to determine the TA-repeat number of the TATA box.2 (G71R mutation) In the jaundice group, the genotype distribution for G71R mutation was as follows : 52 G/G, three G/R and no R/R infants, and the mutated allele frequency was 0.027. In the non-jaundice group, genotype distribution for the mutation was as follows : 47 G/G, three G/R and no R/R infants, and the mutated allele frequency was 0.030.3 (G493R mutation) In the jaundice group, the genotype distribution for G493R mutation was as follows : 50 G/G, one G/R and no R/R infants, and the mutated allele frequency was 0.009. In the non-jaundice group, genotype distribution for the mutation was as follows : 50 G/G, no G/R and no R/R infants, and the mutated allele frequency was 0.000.4 (variant TATA box) In the jaundice group, the genotype distribution for TA-7 variant was as follows : 41 TA-6/TA-6, ten TA-6/TA-7 and four TA-7/TA-7 infants, and the mutated allele frequency was 0.16. In the non-jaundice group, genotype distribution for the mutation was as follows : 43 TA-6/TA-6, six TA-6/TA-7 and one TA-7/TA-7 infants, and the mutated allele frequency was 0.08.5 (Conclusion) The UGT1A1 mutations were not rare in Malay-Malaysian infants (〜30%), indicating the high incidence of Gilbert syndrome in the Malaysian population. The UGT1A1 mutations, especially variant TATA-box, were found more frequently in the jaundice group, suggesting that they are risk factors for the development of neonatal jaundice.
1(目的)为了阐明 UGT1A1 突变是否导致东南亚人群新生儿黄疸高发,我们筛查了马来裔马来西亚人群中的突变。共有 105 名马来裔马来西亚新生儿参与这项研究:55 名患有黄疸,50 名没有黄疸(非黄疸)。采用变性高效液相色谱(DHPLC)检测突变,GeneScan分析确定TATA盒的TA重复次数。2(G71R突变)黄疸组G71R突变基因型分布为:52个G/G、3个G/R和无R/R婴儿,突变等位基因频率为0.027。在非黄疸组中,突变的基因型分布如下:47个G/G、3个G/R和无R/R婴儿,突变等位基因频率为0.030.3(G493R突变) 在黄疸组中,G493R突变的基因型分布如下:50个G/G、1个G/R和无R/R婴儿,以及突变等位基因频率为 0.009。在非黄疸组中,突变的基因型分布如下:50个G/G、无G/R和无R/R婴儿,突变等位基因频率为0.000.4(变异TATA盒) 在黄疸组中,TA-7变异的基因型分布如下:41个TA-6/TA-6、10个TA-6/TA-7和4个TA-7/TA-7婴儿,以及突变者 等位基因频率为0.16。在非黄疸组中,突变基因型分布如下:43个TA-6/TA-6、6个TA-6/TA-7和1个TA-7/TA-7婴儿,突变等位基因频率为0.08.5(结论)UGT1A1突变在马来裔马来西亚婴儿中并不罕见(〜30%),表明马来西亚人群中吉尔伯特综合症的发病率很高。 UGT1A1突变,尤其是TATA-box突变,在黄疸组中更常见,表明它们是新生儿黄疸发生的危险因素。
项目成果
期刊论文数量(14)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Screening for G71R mutation of the UGT1A1 gene in the Javanese-Indonesian and Malaysian populations
在爪哇-印度尼西亚和马来西亚人群中筛查 UGT1A1 基因的 G71R 突变
- DOI:
- 发表时间:2004
- 期刊:
- 影响因子:0
- 作者:Retono;Sutomo
- 通讯作者:Sutomo
Screening for G71R mutation of the UGT1A1 gene in the Javanese-Indonesian and Malaysian populations.
在爪哇-印度尼西亚和马来西亚人群中筛查 UGT1A1 基因的 G71R 突变。
- DOI:
- 发表时间:2004
- 期刊:
- 影响因子:0
- 作者:Retono;Sutomo
- 通讯作者:Sutomo
Retno Sutomo, Hisahide Nishio: "Screening for G71R mutation of the UGT1A1 gene in the and Malay-Malaysian populations"Pediatrics International. 46-5(未定). (2004)
Retno Sutomo、Hisahide Nishio:“在马来-马来西亚人群中筛选 UGT1A1 基因的 G71R 突变”国际儿科 46-5(待定)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Poor correlation between hemolysis and neonatal jaundice in Malaysian G6PD-deficient babies
马来西亚 G6PD 缺乏婴儿的溶血与新生儿黄疸之间的相关性较差
- DOI:
- 发表时间:2005
- 期刊:
- 影响因子:0
- 作者:Narazah Mohd.;Yusoff
- 通讯作者:Yusoff
Poor correlation between hemolysis and neonatal jaundice in Malyaysian G6PD-deficient babies
马来西亚 G6PD 缺乏婴儿的溶血与新生儿黄疸之间的相关性较差
- DOI:
- 发表时间:2005
- 期刊:
- 影响因子:0
- 作者:Narazah Mohd.;Yusoff
- 通讯作者:Yusoff
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
NISHIO Hisahide其他文献
NISHIO Hisahide的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('NISHIO Hisahide', 18)}}的其他基金
Establishment of treatment strategy for spinal muscular atrophybased on the SMN2gene transcription control
基于SMN2基因转录控制的脊髓性肌萎缩症治疗策略的建立
- 批准号:
22591127 - 财政年份:2010
- 资助金额:
$ 7.36万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of Therapy for Spinal Muscular Atrophy Based on the Spliring Modulation Technology
基于Spliring调制技术的脊髓性肌萎缩症治疗方法研究进展
- 批准号:
18591151 - 财政年份:2006
- 资助金额:
$ 7.36万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Screening system for chemicals attacking pre-mRNA splicing machinery in cells
攻击细胞内前 mRNA 剪接机制的化学物质筛选系统
- 批准号:
13670334 - 财政年份:2001
- 资助金额:
$ 7.36万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular biological studies on environmental chemical pollutants interfering with endocrine systems
环境化学污染物干扰内分泌系统的分子生物学研究
- 批准号:
10670350 - 财政年份:1998
- 资助金额:
$ 7.36万 - 项目类别:
Grant-in-Aid for Scientific Research (C)